<DOC>
	<DOCNO>NCT02604940</DOCNO>
	<brief_summary>The purpose study determine whether single bolus dose dexmedetomidine administer bariatric surgery effect amount narcotic pain medication require individual surgery . Patients undergo weight loss surgery randomize two group - group one -dexmedetomidine group group two- control group . Both group receive standard anesthetic . Control group receive weight base dose fentanyl ( standard narcotic pain reliever ) , intravenous acetaminophen ( non-narcotic pain reliever ) , 60ml saline . Experimental group receive weight base dose fentanyl ( standard narcotic pain reliever ) , intravenous acetaminophen ( non-narcotic pain reliever ) , dexmedetomidine ( give 1mcg/kg 10 minute Intravenous ) . The Patient awaken surgery post anesthetic recovery unit give patient control analgesia ( PCA ) pump hydromorphone ( long act narcotic pain reliever ) . The amount hydromorphone use record PACU nurse electronic health record ( routine practice ) two group compare pain medicine requirement . Secondary endpoint Visual Analog Score ( VAS ) pain score , respiratory rate , heart rate , blood pressure oxygen saturation respiratory rate . All record 30,60,90,120 240 minute electronic medical record PACU compare two group . All data - Intra operative Post -operative - Post Anesthesia Care Unit ( PACU ) data retrieve electronic Medical record ( EMR ) . All intra-operative data automatically compute patient EMR . All PACU data routinely enter EMR PACU nurse include PCA data .</brief_summary>
	<brief_title>Evaluation Dexmedetomidine Post-operative Narcotic Requirements Pain Scores Bariatric Patients</brief_title>
	<detailed_description>This study evaluate postoperative opioid spar effect dexmedetomidine give single bolus dose intraoperatively . Dexmedetomidine agonist Î±2-adrenergic receptor sedative medication use intensive care unit anesthesiologists unique ability provide sedation without cause respiratory depression . Recently , receive attention potential additive analgesia . The study population patient undergo gastric bypass surgery . The study population bariatric surgery patient choose due high prevalence sleep apnea Pickwickian component worsen opioid analgesia postoperative period . The purpose study test whether use single bolus dose dexmedetomidine addition standard dose pain regimen decrease postoperative narcotic requirement compare standard dose pain regimen alone . The secondary purpose study whether single bolus dose dexmedetomidine reduces respiratory rate , heart rate , systolic mean blood pressure , patient PCA demand bolus request VAS pain score postoperative period . The overall goal study establish evidence dexmedetomidine 's role multimodal pain relief bariatric surgery population possibility patient subgroup follow</detailed_description>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Narcotics</mesh_term>
	<criteria>Patients must undergo open bariatric surgery WVUHruby hospital . They must ASA class 1 , 2 3 . Consented individual . They must age 18 55 . History bradycardia tachybrady syndrome HR &lt; 45 . 1st degree heart block high . Patient refusal . On pain medication reason 24 hr within 2 week procedure . Allergy medication . History alcohol drug abuse . History Cardiac/ liver/ kidney disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Postoperative narcotic requirement</keyword>
	<keyword>Dexmedetomidine</keyword>
	<keyword>Bariatric Surgery</keyword>
</DOC>